Lyme disease
The Paris-based startup plans to use €1.5 million in pre-seed funding to support R&D on a test kit and deliver preclinical data by early 2025.
Startup En Carta Gets €1.5M for Development of Lyme Disease Test
The Paris-based firm will use the money to support the development of its Lyme disease test kit that will be used for early detection following a tick bite.
The firm expects to make maintaining its Nasdaq compliance a priority as it looks to boost revenues by increasing adoption of its test panels.
HHS, Steven & Alexandra Cohen Foundation Award $2M to Lyme Disease Dx Projects
Ten teams participated in a virtual accelerator designed to help them refine their concepts for detecting active Lyme disease infections.
The Massachusetts-based startup aims to advance testing for parasitic and viral diseases including Chagas, Zika, Lyme, and tapeworm and liver fluke infections.